Baptiste S.
- Country
- France
- Department
- Oncologie
Research Overview
- Efficacy and Safety of Elinzanetant in Treating Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy in Hormone-Receptor Positive Breast Cancer Patients
- Efficacy and Safety of Fezolinetant in Treating Vasomotor Symptoms in Hormone Receptor-Positive Breast Cancer Patients on Adjuvant Endocrine Therapy
- Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in patients treated for human papilloma virus related high-grade squamous intraepithelial lesions.(BioHPV)
Data & Insights
Has run more than one trial at 13 of 150 partner sites.
Specializations
Oncology and Women's Health
This investigator specializes in treating hormone receptor-positive breast cancer patients, with particular attention to managing treatment-related symptoms.
- Breast Cancer Management
- Endocrine Therapy
- Treatment Side Effects
The research focus includes therapeutic approaches for patients undergoing adjuvant endocrine therapy.
Symptom Management
Primary expertise centers on addressing vasomotor symptoms (VMS) in cancer patients, particularly exploring innovative treatments for therapy-induced hot flashes.
- Hot Flash Management
- Quality of Life Improvement
- Therapeutic Interventions
The investigator studies novel compounds for managing moderate to severe VMS in cancer therapy.
Preventive Medicine
Focuses on therapeutic strategies for women at high risk for developing hormone-receptor positive breast cancer, including preventive interventions and symptom management.
- Risk Assessment
- Preventive Strategies
- Patient Monitoring
Emphasis on developing comprehensive treatment approaches for both current patients and high-risk individuals.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.